PQ 437
437. Deputy Brendan Howlin asked the Minister for Health the consideration that has been given to providing the drug Nusinersen to those persons suffering from type 1 spinal muscular atrophy; if his attention has been drawn to the fact that doctors are reporting this drug to be the first to have clinically meaningful outcomes for children with this condition; the efforts that can be made to speed up access to this drug for those persons affected; and if he will make a statement on the matter. [2683/17]
Introduced
24 January 2017
Last action
—
Status
written
Sponsors
—
Subjects
Discovery layer
Source updated
24 January 2017
Summary
437. Deputy Brendan Howlin asked the Minister for Health the consideration that has been given to providing the drug Nusinersen to those persons suffering from type 1 spinal muscular atrophy; if his attention has been drawn to the fact that doctors are reporting this drug to be the first to have clinically meaningful outcomes for children with this condition; the efforts that can be made to speed up access to this drug for those persons affected; and if he will make a statement on the matter. [2683/17]
This text is taken from the official record. PoliticalRepo does not editorialize.
Timeline
No timeline events have been ingested for this record yet.
Votes
No vote records are attached yet.
Versions
No version snapshots stored. Document URLs remain at the source.
Documents
1 official file
Medicinal Products Availability
Medicinal Products Availability
xml · EN · 24 January 2017
Sponsors
No sponsors or actors listed by the source.
Related records
No cross-record relationships stored yet.
Sources
PoliticalRepo is an index and interpretation layer, not the authoritative legal source.
- Official source: https://www.oireachtas.ie/en/debates/question/2017-01-24/437/
- Open data entity: https://data.oireachtas.ie/ie/oireachtas/question/2017-01-24/pq_437